Ciprofloxacin Lactate is a second-generation fluoroquinolone antibiotic utilized to treat severe bacterial infections involving the lungs, skin, blood, bone, joints, kidneys, and gastrointestinal tract.… Read more
Ciprofloxacin Lactate is a second-generation fluoroquinolone antibiotic utilized to treat severe bacterial infections involving the lungs, skin, blood, bone, joints, kidneys, and gastrointestinal tract. This compound functions by inhibiting bacterial DNA gyrase and topoisomerase IV enzymes, which effectively prevents bacterial DNA replication and cell division. This category offers high-quality reference standards for Ciprofloxacin Lactate, including critical pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope-labelled compounds. Pharmaceutical laboratories rely on these specialized materials for robust impurity profiling, method validation, and rigorous quality control protocols during the synthesis and formulation of the drug. By utilizing these precise analytical standards, researchers can ensure the accuracy of their testing procedures and compliance with regulatory requirements throughout the drug development lifecycle.